(Q54304275)

27 May 2018

title

Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A. (English)

1 reference

27 May 2018

0 references

3

M Dohlsten

1 reference

27 May 2018

Gunnar Hedlund

series ordinal

2

object named as

G Hedlund

1 reference

27 May 2018

author name string

P A Lando

series ordinal

1

1 reference

27 May 2018

T Kalland

series ordinal

4

1 reference

27 May 2018

publication date

1 January 1991

1 reference

27 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

27 May 2018

volume

33

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

page(s)

231-237

1 reference

27 May 2018

Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells

cites work

1 reference

12 December 2020

Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. comparison with anti-proliferative activity by RIL1-β, RTNF-α, RIFN-γ, RIl4 and their combinations

1 reference

12 December 2020

The TcR-CD3 complex is required for activation of human lymphocytes with staphylococcal enterotoxin A

1 reference

12 December 2020

Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3

1 reference

12 December 2020

Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro

1 reference

12 December 2020

Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR

1 reference

12 December 2020

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

V beta-specific stimulation of human T cells by staphylococcal toxins.

1 reference

12 December 2020

Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis

1 reference

12 December 2020

Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.

1 reference

12 December 2020

The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice

1 reference

12 December 2020

Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines

1 reference

12 December 2020

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes

1 reference

12 December 2020

Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus

1 reference

12 December 2020

Accessory cells, dendritic cells, or monocytes, are required for the lymphokine-activated killer cell induction from resting T cell but not from natural killer cell precursors

1 reference

12 December 2020

Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.

1 reference

12 December 2020

Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.

1 reference

12 December 2020

The staphylococcal enterotoxins and their relatives.

1 reference

12 December 2020

Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells

1 reference

12 December 2020

Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells

1 reference

12 December 2020

Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.

1 reference

12 December 2020

Superantigenicity of streptococcal M protein

1 reference

12 December 2020

Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2

1 reference

12 December 2020

Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V gamma 9 region

1 reference

12 December 2020

Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin

1 reference

12 December 2020

Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01744942

1 reference

27 May 2018

1 reference

27 May 2018